Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Microbial Genomics
|
February 3, 2022
Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of <i>Salmonella</i>, <i>Escherichia coli</i> and <i>Listeria</i>
Patrick K Mitchell, Leyi Wang, Bryce J Stanhope, et al.
Mbio
|
October 14, 2020
From People to <i>Panthera</i>: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo
Denise McAloose, Melissa Laverack, Leyi Wang, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
BMC Veterinary Research
|
May 8, 2019
Enhancing the one health initiative by using whole genome sequencing to monitor antimicrobial resistance of animal pathogens: Vet-LIRN collaborative project with veterinary diagnostic laboratories in United States and Canada
Olgica Ceric, Gregory H Tyson, Laura B Goodman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023
Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report
|
November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021
Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Microbial Genomics
|
February 3, 2022
Multi-laboratory evaluation of the Illumina iSeq platform for whole genome sequencing of <i>Salmonella</i>, <i>Escherichia coli</i> and <i>Listeria</i>
Patrick K Mitchell, Leyi Wang, Bryce J Stanhope, et al.
Mbio
|
October 14, 2020
From People to <i>Panthera</i>: Natural SARS-CoV-2 Infection in Tigers and Lions at the Bronx Zoo
Denise McAloose, Melissa Laverack, Leyi Wang, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
BMC Veterinary Research
|
May 8, 2019
Enhancing the one health initiative by using whole genome sequencing to monitor antimicrobial resistance of animal pathogens: Vet-LIRN collaborative project with veterinary diagnostic laboratories in United States and Canada
Olgica Ceric, Gregory H Tyson, Laura B Goodman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023
Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report
|
November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021
Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
Page
of 5